Skip to main content
. 2017 Jun 23;12(6):e0179798. doi: 10.1371/journal.pone.0179798

Table 1. KPC34 is active against ALL in vitro in the nanomolar range.

Cell Line Properties KPC34 IC50 (95% CI)
B6-ALL (Ph+) Murine B ALL, BCR-ABL, ARF- 10.36 nM (8.448–12.7)
SUPB15 (Ph+) Human B cell ALL, BCR-ABL 7.39 nM (6.25–8.73)
Jurkat Human T cell ALL 27.94 nM (22.88–34.12)
MOLT4 Human T cell ALL, heterozygous p53 (point missense mutation) 42.71 nM (32.59–55.96)
CCRF-CEM Human T cell lymphoblastic ALL, compound heterozygote with two p53 point mutations 175.6 nM (146.8–210.0)